Avalo Therapeutics

Avalo Therapeutics, formerly Cerecor & Aevi Genomic, is a clinical stage biotechnology company focused on the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network.

Year Established: 2011 Stock Ticker: AVTX Exchange: NASDAQ

Locations